Industry Research Reports

Home > Reports > Medical Care > Global Peptide Therapeutics Market Research Report 2025

Global Peptide Therapeutics Market Research Report 2025

Industry: Medical Care

Published Date: 2025-05-24

Pages: 94 Pages

Report ld: 3470629

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Peptide Therapeutics Market Size(US$)

CAGR 2025-2031

9.0%

Market Size,2031

USD 74,320

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 44,320 million

Market Forecast in 2031(Value)

US$ 74,320 million

CAGR

9.0%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Peptide Therapeutics was valued at US$ 41000 million in the year 2024 and is projected to reach a revised size of US$ 74320 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Peptide therapeutics are a class of pharmaceutical drugs composed of short chains of amino acids, typically ranging from 2 to 50 residues, that mimic natural peptides in the body. These drugs are designed to interact with specific cellular targets, such as receptors, enzymes, or ion channels, to regulate physiological functions. Due to their high specificity, low toxicity, and favorable safety profiles, peptide drugs are widely used in the treatment of various diseases, including cancer, diabetes, cardiovascular diseases, and infectious conditions. With advances in peptide engineering, formulation, and delivery technologies, peptide therapeutics have become a growing segment of the biopharmaceutical industry.

The Peptide Therapeutics market is driven by the increasing demand for highly specific and efficient treatments for a wide range of diseases, including cancer, diabetes, cardiovascular conditions, and rare genetic disorders. Peptides, due to their high selectivity, low immunogenicity, and close resemblance to natural biological molecules, are well-suited for targeted therapy with fewer side effects. Technological advancements in peptide synthesis, modification, and drug delivery systems have enhanced their stability and extended their half-life, making them more viable for clinical use. Additionally, the growing investment in biopharmaceutical research and development, along with a favorable regulatory environment for innovative therapies, is accelerating the development and approval of peptide-based drugs.

Despite these advantages, the Peptide Therapeutics market faces several challenges, particularly related to drug delivery and manufacturing. Peptides are generally unstable in the gastrointestinal tract and are rapidly degraded by enzymes, limiting their oral bioavailability and often requiring parenteral administration. This can affect patient compliance and limit market penetration. Moreover, the complex and costly manufacturing processes for peptide drugs, including synthesis, purification, and formulation, pose economic and technical barriers, especially for smaller biotech firms. Overcoming these limitations through innovative formulation strategies and cost-efficient production methods is critical for ensuring broader clinical adoption and long-term market growth.

Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%. North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent. In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.

This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics.

The Peptide Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Aurinia Pharmaceuticals
BioMarin Pharmaceutical
Apellis Pharmaceuticals
Lantheus
CSL Vifor Group

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Injection
Oral
Other

Segment by Application

Cancer
Metabolic Disorders
Central Nervous System
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Injection

1.2.3 Oral

1.2.4 Other

1.3 Market by Application

1.3.1 Global Peptide Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Metabolic Disorders

1.3.4 Central Nervous System

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide Therapeutics Market Perspective (2020-2031)

2.2 Global Peptide Therapeutics Growth Trends by Region

2.2.1 Global Peptide Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Peptide Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Peptide Therapeutics Market Dynamics

2.3.1 Peptide Therapeutics Industry Trends

2.3.2 Peptide Therapeutics Market Drivers

2.3.3 Peptide Therapeutics Market Challenges

2.3.4 Peptide Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide Therapeutics Players by Revenue

3.1.1 Global Top Peptide Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Peptide Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Top Peptide Therapeutics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide Therapeutics Revenue

3.4 Global Peptide Therapeutics Market Concentration Ratio

3.4.1 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Revenue in 2024

3.5 Global Key Players of Peptide Therapeutics Head office and Area Served

3.6 Global Key Players of Peptide Therapeutics, Product and Application

3.7 Global Key Players of Peptide Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Therapeutics Breakdown Data by Type

4.1 Global Peptide Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Peptide Therapeutics Forecasted Market Size by Type (2026-2031)

5 Peptide Therapeutics Breakdown Data by Application

5.1 Global Peptide Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Peptide Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide Therapeutics Market Size (2020-2031)

6.2 North America Peptide Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide Therapeutics Market Size by Country (2020-2025)

6.4 North America Peptide Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide Therapeutics Market Size (2020-2031)

7.2 Europe Peptide Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide Therapeutics Market Size by Country (2020-2025)

7.4 Europe Peptide Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Peptide Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide Therapeutics Market Size (2020-2031)

9.2 Latin America Peptide Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Peptide Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Peptide Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Peptide Therapeutics Introduction

11.1.4 Sanofi Revenue in Peptide Therapeutics Business (2020-2025)

11.1.5 Sanofi Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Peptide Therapeutics Introduction

11.2.4 Teva Revenue in Peptide Therapeutics Business (2020-2025)

11.2.5 Teva Recent Development

11.3 Novo Nordisk

11.3.1 Novo Nordisk Company Details

11.3.2 Novo Nordisk Business Overview

11.3.3 Novo Nordisk Peptide Therapeutics Introduction

11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Business (2020-2025)

11.3.5 Novo Nordisk Recent Development

11.4 Takeda

11.4.1 Takeda Company Details

11.4.2 Takeda Business Overview

11.4.3 Takeda Peptide Therapeutics Introduction

11.4.4 Takeda Revenue in Peptide Therapeutics Business (2020-2025)

11.4.5 Takeda Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Peptide Therapeutics Introduction

11.5.4 Eli Lilly Revenue in Peptide Therapeutics Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Peptide Therapeutics Introduction

11.6.4 AstraZeneca Revenue in Peptide Therapeutics Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Novartis

11.7.1 Novartis Company Details

11.7.2 Novartis Business Overview

11.7.3 Novartis Peptide Therapeutics Introduction

11.7.4 Novartis Revenue in Peptide Therapeutics Business (2020-2025)

11.7.5 Novartis Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Peptide Therapeutics Introduction

11.8.4 AbbVie Revenue in Peptide Therapeutics Business (2020-2025)

11.8.5 AbbVie Recent Development

11.9 Ipsen

11.9.1 Ipsen Company Details

11.9.2 Ipsen Business Overview

11.9.3 Ipsen Peptide Therapeutics Introduction

11.9.4 Ipsen Revenue in Peptide Therapeutics Business (2020-2025)

11.9.5 Ipsen Recent Development

11.10 Ferring

11.10.1 Ferring Company Details

11.10.2 Ferring Business Overview

11.10.3 Ferring Peptide Therapeutics Introduction

11.10.4 Ferring Revenue in Peptide Therapeutics Business (2020-2025)

11.10.5 Ferring Recent Development

11.11 Merck

11.11.1 Merck Company Details

11.11.2 Merck Business Overview

11.11.3 Merck Peptide Therapeutics Introduction

11.11.4 Merck Revenue in Peptide Therapeutics Business (2020-2025)

11.11.5 Merck Recent Development

11.12 The Medicines

11.12.1 The Medicines Company Details

11.12.2 The Medicines Business Overview

11.12.3 The Medicines Peptide Therapeutics Introduction

11.12.4 The Medicines Revenue in Peptide Therapeutics Business (2020-2025)

11.12.5 The Medicines Recent Development

11.13 J & J

11.13.1 J & J Company Details

11.13.2 J & J Business Overview

11.13.3 J & J Peptide Therapeutics Introduction

11.13.4 J & J Revenue in Peptide Therapeutics Business (2020-2025)

11.13.5 J & J Recent Development

11.14 Aurinia Pharmaceuticals

11.14.1 Aurinia Pharmaceuticals Company Details

11.14.2 Aurinia Pharmaceuticals Business Overview

11.14.3 Aurinia Pharmaceuticals Peptide Therapeutics Introduction

11.14.4 Aurinia Pharmaceuticals Revenue in Peptide Therapeutics Business (2020-2025)

11.14.5 Aurinia Pharmaceuticals Recent Development

11.15 BioMarin Pharmaceutical

11.15.1 BioMarin Pharmaceutical Company Details

11.15.2 BioMarin Pharmaceutical Business Overview

11.15.3 BioMarin Pharmaceutical Peptide Therapeutics Introduction

11.15.4 BioMarin Pharmaceutical Revenue in Peptide Therapeutics Business (2020-2025)

11.15.5 BioMarin Pharmaceutical Recent Development

11.16 Apellis Pharmaceuticals

11.16.1 Apellis Pharmaceuticals Company Details

11.16.2 Apellis Pharmaceuticals Business Overview

11.16.3 Apellis Pharmaceuticals Peptide Therapeutics Introduction

11.16.4 Apellis Pharmaceuticals Revenue in Peptide Therapeutics Business (2020-2025)

11.16.5 Apellis Pharmaceuticals Recent Development

11.17 Lantheus

11.17.1 Lantheus Company Details

11.17.2 Lantheus Business Overview

11.17.3 Lantheus Peptide Therapeutics Introduction

11.17.4 Lantheus Revenue in Peptide Therapeutics Business (2020-2025)

11.17.5 Lantheus Recent Development

11.18 CSL Vifor Group

11.18.1 CSL Vifor Group Company Details

11.18.2 CSL Vifor Group Business Overview

11.18.3 CSL Vifor Group Peptide Therapeutics Introduction

11.18.4 CSL Vifor Group Revenue in Peptide Therapeutics Business (2020-2025)

11.18.5 CSL Vifor Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Peptide Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Injection

Table 3. Key Players of Oral

Table 4. Key Players of Other

Table 5. Global Peptide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Peptide Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Peptide Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Peptide Therapeutics Market Share by Region (2020-2025)

Table 9. Global Peptide Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Peptide Therapeutics Market Share by Region (2026-2031)

Table 11. Peptide Therapeutics Market Trends

Table 12. Peptide Therapeutics Market Drivers

Table 13. Peptide Therapeutics Market Challenges

Table 14. Peptide Therapeutics Market Restraints

Table 15. Global Peptide Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Peptide Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Peptide Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)

Table 18. Ranking of Global Top Peptide Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Peptide Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Peptide Therapeutics, Product and Application

Table 22. Global Key Players of Peptide Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Peptide Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Peptide Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Peptide Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Peptide Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Peptide Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Peptide Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Peptide Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Peptide Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Peptide Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Peptide Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Peptide Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Peptide Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Peptide Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Peptide Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Peptide Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Peptide Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Peptide Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Peptide Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Peptide Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Peptide Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Peptide Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Peptide Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Peptide Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Peptide Therapeutics Product

Table 50. Sanofi Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Sanofi Recent Development

Table 52. Teva Company Details

Table 53. Teva Business Overview

Table 54. Teva Peptide Therapeutics Product

Table 55. Teva Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Teva Recent Development

Table 57. Novo Nordisk Company Details

Table 58. Novo Nordisk Business Overview

Table 59. Novo Nordisk Peptide Therapeutics Product

Table 60. Novo Nordisk Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Novo Nordisk Recent Development

Table 62. Takeda Company Details

Table 63. Takeda Business Overview

Table 64. Takeda Peptide Therapeutics Product

Table 65. Takeda Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Takeda Recent Development

Table 67. Eli Lilly Company Details

Table 68. Eli Lilly Business Overview

Table 69. Eli Lilly Peptide Therapeutics Product

Table 70. Eli Lilly Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Eli Lilly Recent Development

Table 72. AstraZeneca Company Details

Table 73. AstraZeneca Business Overview

Table 74. AstraZeneca Peptide Therapeutics Product

Table 75. AstraZeneca Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 76. AstraZeneca Recent Development

Table 77. Novartis Company Details

Table 78. Novartis Business Overview

Table 79. Novartis Peptide Therapeutics Product

Table 80. Novartis Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 81. Novartis Recent Development

Table 82. AbbVie Company Details

Table 83. AbbVie Business Overview

Table 84. AbbVie Peptide Therapeutics Product

Table 85. AbbVie Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 86. AbbVie Recent Development

Table 87. Ipsen Company Details

Table 88. Ipsen Business Overview

Table 89. Ipsen Peptide Therapeutics Product

Table 90. Ipsen Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 91. Ipsen Recent Development

Table 92. Ferring Company Details

Table 93. Ferring Business Overview

Table 94. Ferring Peptide Therapeutics Product

Table 95. Ferring Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 96. Ferring Recent Development

Table 97. Merck Company Details

Table 98. Merck Business Overview

Table 99. Merck Peptide Therapeutics Product

Table 100. Merck Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 101. Merck Recent Development

Table 102. The Medicines Company Details

Table 103. The Medicines Business Overview

Table 104. The Medicines Peptide Therapeutics Product

Table 105. The Medicines Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 106. The Medicines Recent Development

Table 107. J & J Company Details

Table 108. J & J Business Overview

Table 109. J & J Peptide Therapeutics Product

Table 110. J & J Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 111. J & J Recent Development

Table 112. Aurinia Pharmaceuticals Company Details

Table 113. Aurinia Pharmaceuticals Business Overview

Table 114. Aurinia Pharmaceuticals Peptide Therapeutics Product

Table 115. Aurinia Pharmaceuticals Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 116. Aurinia Pharmaceuticals Recent Development

Table 117. BioMarin Pharmaceutical Company Details

Table 118. BioMarin Pharmaceutical Business Overview

Table 119. BioMarin Pharmaceutical Peptide Therapeutics Product

Table 120. BioMarin Pharmaceutical Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 121. BioMarin Pharmaceutical Recent Development

Table 122. Apellis Pharmaceuticals Company Details

Table 123. Apellis Pharmaceuticals Business Overview

Table 124. Apellis Pharmaceuticals Peptide Therapeutics Product

Table 125. Apellis Pharmaceuticals Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 126. Apellis Pharmaceuticals Recent Development

Table 127. Lantheus Company Details

Table 128. Lantheus Business Overview

Table 129. Lantheus Peptide Therapeutics Product

Table 130. Lantheus Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 131. Lantheus Recent Development

Table 132. CSL Vifor Group Company Details

Table 133. CSL Vifor Group Business Overview

Table 134. CSL Vifor Group Peptide Therapeutics Product

Table 135. CSL Vifor Group Revenue in Peptide Therapeutics Business (2020-2025) & (US$ Million)

Table 136. CSL Vifor Group Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

Table 140. Authors List of This Report

List of Figures

Figure 1. Peptide Therapeutics Picture

Figure 2. Global Peptide Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Injection Features

Figure 5. Oral Features

Figure 6. Other Features

Figure 7. Global Peptide Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Peptide Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Cancer Case Studies

Figure 10. Metabolic Disorders Case Studies

Figure 11. Central Nervous System Case Studies

Figure 12. Other Case Studies

Figure 13. Peptide Therapeutics Report Years Considered

Figure 14. Global Peptide Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Peptide Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Peptide Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Peptide Therapeutics Market Share by Players in 2024

Figure 18. Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Peptide Therapeutics Revenue in 2024

Figure 20. North America Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Peptide Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Peptide Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Peptide Therapeutics Market Share by Region (2020-2031)

Figure 34. China Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Peptide Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Peptide Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Peptide Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Sanofi Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 50. Teva Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 51. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 52. Takeda Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 55. Novartis Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 56. AbbVie Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 57. Ipsen Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 58. Ferring Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 59. Merck Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 60. The Medicines Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 61. J & J Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 62. Aurinia Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 63. BioMarin Pharmaceutical Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 64. Apellis Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 65. Lantheus Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 66. CSL Vifor Group Revenue Growth Rate in Peptide Therapeutics Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Peptide Therapeutics market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Peptide Therapeutics market is 9.0% 2025 to 2031.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Peptide Therapeutics market? shouQi

What was the global market size of Peptide Therapeutics in 2025? shouQi

What was the global market size of Peptide Therapeutics in 2031? shouQi

Related Reports

Global Peptide Therapeutics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Peptide Therapeutics market is projected to grow from US$ 44320 million in 2025 to US$ 80340 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-02-14
Pages: 152
USD 4900.00
(Single User License)
Global Peptide Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Peptide Therapeutics market size was US$ 44320 million in 2025 and is forecast to reach a readjusted size of US$ 80340 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published Date: 2026-02-14
Pages: 108
USD 4250.00
(Single User License)
Global Peptide Therapeutics Market Research Report 2026
The global Peptide Therapeutics market was valued at US$ 44320 million in 2025 and is anticipated to reach US$ 80340 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-02-14
Pages: 131
USD 2900.00
(Single User License)
Peptide Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peptide Therapeutics was estimated to be worth US$ 44320 million in 2025 and is projected to reach US$ 80340 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published Date: 2026-02-14
Pages: 122
USD 3950.00
(Single User License)
Global Peptide Therapeutics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peptide Therapeutics market is projected to grow from US$ 41000 million in 2024 to US$ 74320 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 151
USD 4900.00
(Single User License)
Peptide Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide Therapeutics was estimated to be worth US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-05-24
Pages: 139
USD 3950.00
(Single User License)
Global Peptide Therapeutics Market Insights, Forecast to 2031
The global Peptide Therapeutics market is projected to grow from US$ 44320 million in 2025 to US$ 74320 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
Published Date: 2025-05-24
Pages: 158
USD 4900.00
(Single User License)
Global Peptide Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Peptide Therapeutics market size was US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-05-24
Pages: 110
USD 4250.00
(Single User License)
Global Peptide Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Peptide Therapeutics was estimated to be worth US$ 41000 million and is forecast to reach approximately US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 143
USD 5900.00
(Single User License)
Peptide Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide Therapeutics was estimated to be worth US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 120
USD 3950.00
(Single User License)

Global Peptide Therapeutics Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Peptide Therapeutics market is projected to grow from US$ 44320 million in 2025 to US$ 80340 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-02-14
Pages: 152
USD 4900.00 (Single User License)
Global Peptide Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Peptide Therapeutics market size was US$ 44320 million in 2025 and is forecast to reach a readjusted size of US$ 80340 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Published: 2026-02-14
Pages: 108
USD 4250.00 (Single User License)
Global Peptide Therapeutics Market Research Report 2026
The global Peptide Therapeutics market was valued at US$ 44320 million in 2025 and is anticipated to reach US$ 80340 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-02-14
Pages: 131
USD 2900.00 (Single User License)
Peptide Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Peptide Therapeutics was estimated to be worth US$ 44320 million in 2025 and is projected to reach US$ 80340 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-02-14
Pages: 122
USD 3950.00 (Single User License)
Global Peptide Therapeutics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Peptide Therapeutics market is projected to grow from US$ 41000 million in 2024 to US$ 74320 million by 2031, at a CAGR of 9.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 151
USD 4900.00 (Single User License)
Peptide Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide Therapeutics was estimated to be worth US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-05-24
Pages: 139
USD 3950.00 (Single User License)
Global Peptide Therapeutics Market Insights, Forecast to 2031
The global Peptide Therapeutics market is projected to grow from US$ 44320 million in 2025 to US$ 74320 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
Published: 2025-05-24
Pages: 158
USD 4900.00 (Single User License)
Global Peptide Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Peptide Therapeutics market size was US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-05-24
Pages: 110
USD 4250.00 (Single User License)
Global Peptide Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Peptide Therapeutics was estimated to be worth US$ 41000 million and is forecast to reach approximately US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 143
USD 5900.00 (Single User License)
Peptide Therapeutics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Peptide Therapeutics was estimated to be worth US$ 41000 million in 2024 and is forecast to a readjusted size of US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 120
USD 3950.00 (Single User License)